A federal judge in the Eastern District of Texas erased the Consumer Financial Protection Bureau’s rule banning medical debt from credit reports on July 11, 2025, acting on a joint request from the agency itself and the credit union trade group that had sued to stop it. The ruling ended what would have been the broadest medical-debt protection ever written into federal credit law. It left completely untouched a narrower policy that Equifax, Experian and TransUnion had put in place on their own two years earlier — a voluntary threshold that already strips medical collections under $500 off close to seventy percent of the credit files that carried them.
The Regulation V Rule Died By Joint Motion, Not Trial
The Consumer Financial Protection Bureau finalized the rule on January 7, 2025, amending Regulation V under the Fair Credit Reporting Act. It barred creditors from considering a borrower’s medical debt when deciding whether to extend credit, and it barred consumer reporting agencies from including medical debt information on credit reports at all, a broader ban than anything the three bureaus had ever adopted on their own. The rule was scheduled to take effect March 17, 2025, but a federal court stayed it before that date arrived, pushing its effective date to June 15, 2025, while a coalition of credit unions pressed its lawsuit against the agency.
That lawsuit ended on July 11, 2025, when the U.S. District Court for the Eastern District of Texas vacated the rule entirely in Cornerstone Credit Union League v. CFPB, on a joint motion from the Bureau and the plaintiffs who had sued to block it. The court found the rule exceeded the agency’s statutory authority because the Fair Credit Reporting Act permits furnishing and considering coded medical debt information, so long as the coding does not identify a specific provider or reveal the nature of the services rendered. The same ruling held that federal law preempts state statutes attempting to impose similar medical-debt reporting bans, closing off a state-level substitute for the vacated rule.
The Bureau did not defend the rule on the merits; it asked the court to vacate it. Its own rule page now notes that “the materials relating to the FCRA Medical Debt Rule on the Bureau’s website are for reference only,” language that treats an eighteen-month-old rulemaking as a dead letter rather than a live regulation awaiting appeal.
Free retirement updates: Keep more of your Social Security and savings with plain-English updates on the changes, deadlines, and costly mistakes retirees miss. Subscribe free.
A Threshold The Three Bureaus Set For Themselves in 2023
None of that touched the narrower policy Equifax, Experian and TransUnion adopted on their own, years before the CFPB ever wrote Regulation V. On April 11, 2023, the three companies jointly announced they would remove medical collection debt carrying an initial reported balance under $500 from U.S. credit files, a step the companies said would clear nearly 70 percent of all medical collection tradelines then sitting on consumer reports. The move built on an earlier 2022 commitment: as of July 1 of that year, the bureaus had already stopped including medical collection debt a consumer had paid in full, and had stretched the reporting delay on unpaid medical bills from six months to a full year.
The scale of the earlier problem is why the 2023 pledge mattered on its own terms, independent of anything Congress or the CFPB eventually did. The Bureau’s own research found that 43 million people had unpaid medical bills reflected on their credit reports as of 2021, and medical bills generated more contact from debt collectors than any other category of consumer debt. The $500 floor and the one-year reporting delay were built around that specific population, not around any Regulation V requirement.
The Bureau’s own consumer guidance estimated the threshold would clear medical collections from roughly half of the credit files that carried them, since the change reached every qualifying collection below that dollar line rather than only paid-off ones. Because the policy came from a commitment the three companies made to each other rather than from a rule the CFPB adopted, it never depended on Regulation V surviving a court challenge. The vacatur in Cornerstone Credit Union League erased the federal rule’s text; it did nothing to the bureaus’ 2023 pledge, which sits entirely outside the Fair Credit Reporting Act’s rulemaking process.
No Statute Compels the $500 Floor to Survive
That distinction carries a consequence most people checking a credit report never see. A medical collection above $500, or one still inside the one-year reporting delay, now has no federal ban standing between it and a credit file — the rule written to cover exactly that debt no longer exists, and the same court decision found that a state cannot pass its own law to fill the gap because the Fair Credit Reporting Act preempts it. The only protection actually operating today for smaller, older medical collections is the bureaus’ voluntary sub-$500 floor, which functions as private company policy rather than binding law.
Nothing in the Fair Credit Reporting Act obliges Equifax, Experian or TransUnion to keep that floor at $500, extend it, or maintain it at all. The three companies set the number themselves through a joint announcement, and they could narrow or withdraw it the same way, with a press release rather than a notice-and-comment rulemaking or a lawsuit. Undoing the CFPB’s version required a federal court judgment reached after more than a year of litigation; unwinding the bureaus’ own commitment would require none of that, since no regulation or statute currently locks the $500 threshold in place.
The gap left behind is specific rather than abstract. Households with older, paid-off medical bills or collections under $500 keep the protection the bureaus adopted in 2023, while anyone carrying a larger unpaid medical collection, or one that recently entered collections, now faces the same reporting rules that existed before the CFPB ever proposed Regulation V. The Cornerstone ruling settled the legal question of who has authority to ban medical debt from credit reports nationwide — the answer, for now, is nobody at the federal level — leaving the size of the surviving protection dependent on three companies’ continuing willingness to keep a number they chose voluntarily in the first place.
This article was researched and drafted with the assistance of artificial intelligence.
More Financial Reading
